NMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Nomura Holdings Inc (NMR) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the technical indicators show some bullish momentum, the lack of significant positive catalysts, weak financial performance, and neutral trading sentiment suggest a cautious approach. Holding off for more favorable conditions or stronger signals is advisable.
The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 60.605, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 9.396), which may limit immediate upside potential. Overall, the technical indicators suggest moderate bullishness.
Bullish moving averages and positive MACD expansion suggest some upward momentum in the short term. Gross margin improved significantly YoY, up 14.03%.
Revenue, net income, and EPS all declined YoY in the latest quarter. No significant news or event-driven catalysts. Analysts removed a related company from a conviction list, which could imply reduced confidence. Stock trend analysis shows a potential decline in the next week (-1.18%) and month (-5.47%).
In 2026/Q2, revenue dropped by -5.41% YoY, net income fell by -5.35% YoY, and EPS declined by -4.55% YoY. However, gross margin increased by 14.03% YoY, indicating some operational efficiency improvements.
Goldman Sachs removed a related company from its APAC Conviction List, which may reflect reduced confidence in the sector. No recent upgrades or positive changes in price targets for NMR.
